• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子健康记录嵌入的成人镰状细胞病血管闭塞性发作急诊科治疗个性化疼痛计划:实施前和实施后研究方案

Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.

作者信息

Luo Lingzi, King Allison A, Carroll Yvonne, Baumann Ana A, Brambilla Donald, Carpenter Christopher R, Colla Joseph, Gibson Robert W, Gollan Siera, Hall Greg, Klesges Lisa, Kutlar Abdullah, Lyon Matthew, Melvin Cathy L, Norell Sarah, Mueller Martina, Potter Michael B, Richesson Rachel, Richardson Lynne D, Ryan Gery, Siewny Lauren, Treadwell Marsha, Zun Leslie, Armstrong-Brown Janelle, Cox Lisa, Tanabe Paula

机构信息

Washington University School of Medicine, St Louis, MO, United States.

St Jude Children's Research Hospital, Memphis, TN, United States.

出版信息

JMIR Res Protoc. 2021 Apr 16;10(4):e24818. doi: 10.2196/24818.

DOI:10.2196/24818
PMID:33861209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8087964/
Abstract

BACKGROUND

Individuals living with sickle cell disease often require aggressive treatment of pain associated with vaso-occlusive episodes in the emergency department. Frequently, pain relief is poor. The 2014 National Heart, Lung, and Blood Institute evidence-based guidelines recommended an individualized treatment and monitoring protocol to improve pain management of vaso-occlusive episodes.

OBJECTIVE

This study will implement an electronic health record-embedded individualized pain plan with provider and patient access in the emergency departments of 8 US academic centers to improve pain treatment for adult patients with sickle cell disease. This study will assess the overall effects of electronic health record-embedded individualized pain plans on improving patient and provider outcomes associated with pain treatment in the emergency department setting and explore barriers and facilitators to the implementation process.

METHODS

A preimplementation and postimplementation study is being conducted by all 8 sites that are members of the National Heart, Lung, and Blood Institute-funded Sickle Cell Disease Implementation Consortium. Adults with sickle cell disease aged 18 to 45 years who had a visit to a participating emergency department for vaso-occlusive episodes within 90 days prior to enrollment will be eligible for inclusion. Patients will be enrolled in the clinic or remotely. The target analytical sample size of this study is 160 patient participants (20 per site) who have had an emergency department visit for vaso-occlusive episode treatment at participating emergency departments during the study period. Each site is expected to enroll approximately 40 participants to reach the analytical sample size. The electronic health record-embedded individualized pain plans will be written by the patient's sickle cell disease provider, and sites will work with the local informatics team to identify the best method to build the electronic health record-embedded individualized pain plan with patient and provider access. Each site will adopt required patient and provider implementation strategies and can choose to adopt optional strategies to improve the uptake and sustainability of the intervention. The study is informed by the Technology Acceptance Model 2 and the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework. Provider and patient baseline survey, follow-up survey within 96 hours of an emergency department vaso-occlusive episode visit, and selected qualitative interviews within 2 weeks of an emergency department visit will be performed to assess the primary outcome, patient-perceived quality of emergency department pain treatment, and additional implementation and intervention outcomes. Electronic health record data will be used to analyze individualized pain plan adherence and additional secondary outcomes, such as hospital admission and readmission rates.

RESULTS

The study is currently enrolling study participants. The active implementation period is 18 months.

CONCLUSIONS

This study proposes a structured, framework-informed approach to implement electronic health record-embedded individualized pain plans with both patient and provider access in routine emergency department practice. The results of the study will inform the implementation of electronic health record-embedded individualized pain plans at a larger scale outside of Sickle Cell Disease Implementation Consortium centers.

TRIAL REGISTRATION

ClinicalTrials.gov NCT04584528; https://clinicaltrials.gov/ct2/show/NCT04584528.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/24818.

摘要

背景

镰状细胞病患者在急诊科通常需要积极治疗与血管阻塞性发作相关的疼痛。然而,疼痛缓解情况往往不佳。2014年美国国立心肺血液研究所的循证指南推荐采用个体化治疗和监测方案,以改善血管阻塞性发作的疼痛管理。

目的

本研究将在美国8个学术中心的急诊科实施一项嵌入电子健康记录的个体化疼痛计划,供医护人员和患者使用,以改善成年镰状细胞病患者的疼痛治疗。本研究将评估嵌入电子健康记录的个体化疼痛计划对改善急诊科环境下与疼痛治疗相关的患者和医护人员结局的总体效果,并探索实施过程中的障碍和促进因素。

方法

由美国国立心肺血液研究所资助的镰状细胞病实施联盟的所有8个站点开展一项实施前和实施后的研究。年龄在18至45岁之间、在入组前90天内曾因血管阻塞性发作到参与研究的急诊科就诊的成年镰状细胞病患者将符合纳入条件。患者将在诊所或通过远程方式入组。本研究的目标分析样本量为160名患者参与者(每个站点20名),他们在研究期间因血管阻塞性发作治疗到参与研究的急诊科就诊。每个站点预计将招募约40名参与者以达到分析样本量。嵌入电子健康记录的个体化疼痛计划将由患者的镰状细胞病医护人员编写,各站点将与当地信息学团队合作,确定建立可供患者和医护人员使用的嵌入电子健康记录的个体化疼痛计划的最佳方法。每个站点将采用所需的患者和医护人员实施策略,并可选择采用可选策略,以提高干预措施的接受度和可持续性。本研究以技术接受模型2以及覆盖、有效性、采用、实施和维持框架为依据。将进行医护人员和患者基线调查、在急诊科血管阻塞性发作就诊后96小时内进行随访调查,以及在急诊科就诊后2周内进行选定的定性访谈,以评估主要结局、患者感知的急诊科疼痛治疗质量以及其他实施和干预结局。电子健康记录数据将用于分析个体化疼痛计划的依从性以及其他次要结局,如住院和再入院率。

结果

该研究目前正在招募研究参与者。积极实施期为18个月。

结论

本研究提出了一种结构化的、基于框架的方法,在常规急诊科实践中实施可供患者和医护人员使用的嵌入电子健康记录的个体化疼痛计划。研究结果将为在镰状细胞病实施联盟中心以外的更大范围内实施嵌入电子健康记录的个体化疼痛计划提供参考。

试验注册

ClinicalTrials.gov NCT04584528;https://clinicaltrials.gov/ct2/show/NCT04584528。

国际注册报告识别码(IRRID):DERR1-10.2196/24818。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/50c8fd900993/resprot_v10i4e24818_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/0f10f553f79e/resprot_v10i4e24818_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/75eb87e9a2ef/resprot_v10i4e24818_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/d3424ad1c897/resprot_v10i4e24818_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/50c8fd900993/resprot_v10i4e24818_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/0f10f553f79e/resprot_v10i4e24818_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/75eb87e9a2ef/resprot_v10i4e24818_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/d3424ad1c897/resprot_v10i4e24818_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/50c8fd900993/resprot_v10i4e24818_fig4.jpg

相似文献

1
Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.电子健康记录嵌入的成人镰状细胞病血管闭塞性发作急诊科治疗个性化疼痛计划:实施前和实施后研究方案
JMIR Res Protoc. 2021 Apr 16;10(4):e24818. doi: 10.2196/24818.
2
"The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.“项目没有为我们提供解决方案”:研究团队对实施一项关于电子健康记录嵌入式个体化疼痛计划的看法,该计划用于治疗镰状细胞病成人急诊科血管阻塞性发作。
BMC Health Serv Res. 2023 Nov 13;23(1):1245. doi: 10.1186/s12913-023-10255-7.
3
An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.一项镰状细胞血管阻塞性发作治疗算法和镰状细胞病患者病例管理转诊表在急诊科传播的中断时间序列分析。
J Emerg Nurs. 2021 Jan;47(1):40-49.e1. doi: 10.1016/j.jen.2020.06.001. Epub 2020 Aug 18.
4
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.个体化疼痛方案对急诊科治疗镰状细胞病血管阻塞性发作的影响。
Blood Adv. 2024 Oct 22;8(20):5330-5338. doi: 10.1182/bloodadvances.2023012439.
5
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.将移动健康整合到镰状细胞病护理中以提高羟基脲的使用率:一项疗效与实施研究的方案
JMIR Res Protoc. 2020 Jul 14;9(7):e16319. doi: 10.2196/16319.
6
Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.电子疼痛计划能否改善镰状细胞病相关血管闭塞性疼痛危象的管理?一项混合方法评估。
Int J Med Inform. 2014 Nov;83(11):814-24. doi: 10.1016/j.ijmedinf.2014.08.003. Epub 2014 Aug 17.
7
Time to pain relief: A randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease.缓解疼痛时间:镰状细胞病血管阻塞性发作时急诊科的随机对照试验。
Eur J Haematol. 2023 May;110(5):518-526. doi: 10.1111/ejh.13924. Epub 2023 Jan 23.
8
Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).比较特定患者与基于体重的方案治疗镰状细胞病血管阻塞性发作的临床试验设计(COMPARE-VOE)。
Contemp Clin Trials. 2021 Feb;101:106252. doi: 10.1016/j.cct.2020.106252. Epub 2020 Dec 28.
9
Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.探索急诊科医护人员对镰状细胞病基于体重与个体化血管闭塞性治疗方案的体验及看法。
Adv Emerg Nurs J. 2019 Jan-Mar;41(1):86-97. doi: 10.1097/TME.0000000000000232.
10
Barriers and Facilitators to the Implementation of Family-Centered Technology in Complex Care: Feasibility Study.复杂护理中实施以家庭为中心的技术的障碍和促进因素:可行性研究。
J Med Internet Res. 2022 Aug 23;24(8):e30902. doi: 10.2196/30902.

引用本文的文献

1
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.个体化疼痛方案对急诊科治疗镰状细胞病血管阻塞性发作的影响。
Blood Adv. 2024 Oct 22;8(20):5330-5338. doi: 10.1182/bloodadvances.2023012439.
2
"The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.“项目没有为我们提供解决方案”:研究团队对实施一项关于电子健康记录嵌入式个体化疼痛计划的看法,该计划用于治疗镰状细胞病成人急诊科血管阻塞性发作。
BMC Health Serv Res. 2023 Nov 13;23(1):1245. doi: 10.1186/s12913-023-10255-7.
3

本文引用的文献

1
The Implementation Research Logic Model: a method for planning, executing, reporting, and synthesizing implementation projects.实施研究逻辑模型:一种用于规划、执行、报告和综合实施项目的方法。
Implement Sci. 2020 Sep 25;15(1):84. doi: 10.1186/s13012-020-01041-8.
2
EDSC: Working to Improve Emergency Department Care of Individuals With Sickle Cell Disease.急诊护理支持中心:致力于改善镰状细胞病患者的急诊科护理。
Ann Emerg Med. 2020 Sep;76(3S):S80-S82. doi: 10.1016/j.annemergmed.2020.08.016.
3
A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency Department.
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.制定改善镰状细胞病结局的全球战略:柳叶刀血液学委员会。
Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11.
4
Advancing healthcare equity through dissemination and implementation science.通过传播和实施科学来促进医疗保健公平。
Health Serv Res. 2023 Dec;58 Suppl 3(Suppl 3):327-344. doi: 10.1111/1475-6773.14175. Epub 2023 May 23.
基于调查的急诊科改善镰状细胞病护理障碍的需求评估。
Ann Emerg Med. 2020 Sep;76(3S):S64-S72. doi: 10.1016/j.annemergmed.2020.08.013.
4
Emergency Department Utilization for Patients Living With Sickle Cell Disease: Psychosocial Predictors of Health Care Behaviors.急诊科利用镰状细胞病患者:医疗行为的心理社会预测因素。
Ann Emerg Med. 2020 Sep;76(3S):S56-S63. doi: 10.1016/j.annemergmed.2020.08.018.
5
The Effect of Use of Individualized Pain Plans in Sickle Cell Patients Presenting to the Emergency Department.个体化疼痛方案在急诊科就诊的镰状细胞病患者中的应用效果。
Ann Emerg Med. 2020 Sep;76(3S):S21-S27. doi: 10.1016/j.annemergmed.2020.08.008.
6
"Pain is Subjective": A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries.“疼痛是主观的”:一项在三个国家针对镰状细胞病中疼痛管理的提供者态度和实践的混合方法研究。
J Pain Symptom Manage. 2021 Mar;61(3):474-487. doi: 10.1016/j.jpainsymman.2020.08.029. Epub 2020 Sep 1.
7
Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.美国镰状细胞病青少年和成年患者对其护理质量的认知。
JAMA Netw Open. 2020 May 1;3(5):e206016. doi: 10.1001/jamanetworkopen.2020.6016.
8
The Use of an Electronic Health Record Patient Portal to Access Diagnostic Test Results by Emergency Patients at an Academic Medical Center: Retrospective Study.学术医疗中心急诊患者使用电子健康记录患者门户获取诊断测试结果:回顾性研究
J Med Internet Res. 2019 Jun 28;21(6):e13791. doi: 10.2196/13791.
9
RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review.RE-AIM规划与评估框架:历经20年回顾,适应新科学与实践
Front Public Health. 2019 Mar 29;7:64. doi: 10.3389/fpubh.2019.00064. eCollection 2019.
10
Computerized Clinical Decision Support System for Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: User-Centered Design.急诊科启动丁丙诺啡治疗阿片类物质使用障碍的计算机化临床决策支持系统:以用户为中心的设计
JMIR Hum Factors. 2019 Feb 27;6(1):e13121. doi: 10.2196/13121.